Will Sientra, Inc. (SIEN) Go Down Anytime Soon?

February 15, 2018 - By Maria Brooks

Investors sentiment decreased to 1.52 in Q3 2017. Its down 0.34, from 1.86 in 2017Q2. It dived, as 9 investors sold Sientra, Inc. shares while 14 reduced holdings. 13 funds opened positions while 22 raised stakes. 14.36 million shares or 1.78% more from 14.11 million shares in 2017Q2 were reported.
Blackrock reported 0% stake. Deutsche National Bank Ag has 0% invested in Sientra, Inc. (NASDAQ:SIEN). Tower Research Cap Ltd Liability Corp (Trc) has 0% invested in Sientra, Inc. (NASDAQ:SIEN) for 2,339 shares. Weiss Multi holds 10,000 shares. Ameritas Investment Partners Inc has invested 0% of its portfolio in Sientra, Inc. (NASDAQ:SIEN). California-based Wells Fargo Mn has invested 0% in Sientra, Inc. (NASDAQ:SIEN). Millennium Mgmt Lc holds 0% or 21,084 shares in its portfolio. Bridgeway Mgmt reported 282,500 shares. Royal Retail Bank Of Canada owns 1,279 shares. Driehaus Management Limited Liability invested in 0.34% or 563,244 shares. Northern holds 0% or 149,500 shares. Clarus Ventures Limited Liability Com stated it has 2.73M shares. 66,351 are owned by Prelude Llc. Pura Vida Invs Lc accumulated 187,800 shares or 1.45% of the stock. Creative Planning holds 0% or 26,250 shares.

The stock of Sientra, Inc. (NASDAQ:SIEN) is a huge mover today! The stock increased 3.59% or $0.39 during the last trading session, reaching $11.24. About 127,260 shares traded. Sientra, Inc. (NASDAQ:SIEN) has risen 27.61% since February 15, 2017 and is uptrending. It has outperformed by 10.91% the S&P500.
The move comes after 5 months positive chart setup for the $218.08 million company. It was reported on Feb, 15 by Barchart.com. We have $12.25 PT which if reached, will make NASDAQ:SIEN worth $19.63 million more.

Analysts await Sientra, Inc. (NASDAQ:SIEN) to report earnings on March, 13. They expect $-0.68 earnings per share, down 58.14 % or $0.25 from last year’s $-0.43 per share. After $-0.74 actual earnings per share reported by Sientra, Inc. for the previous quarter, Wall Street now forecasts -8.11 % EPS growth.

Sientra, Inc. (NASDAQ:SIEN) Ratings Coverage

Among 5 analysts covering Sientra (NASDAQ:SIEN), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Sientra had 12 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, February 11. As per Wednesday, August 10, the company rating was reinitiated by William Blair. The firm has “Buy” rating by Stifel Nicolaus given on Friday, January 19. Canaccord Genuity maintained it with “Buy” rating and $14.0 target in Sunday, October 8 report. The company was maintained on Tuesday, September 26 by Stifel Nicolaus. The stock of Sientra, Inc. (NASDAQ:SIEN) has “Outperform” rating given on Wednesday, September 13 by William Blair. The stock has “Buy” rating by Canaccord Genuity on Tuesday, October 17. On Monday, August 28 the stock rating was initiated by Canaccord Genuity with “Buy”. Stifel Nicolaus maintained the shares of SIEN in report on Wednesday, August 9 with “Hold” rating. The stock has “Buy” rating by Canaccord Genuity on Thursday, January 4.

More recent Sientra, Inc. (NASDAQ:SIEN) news were published by: Globenewswire.com which released: “Lubrizol Customer, Sientra, Inc., Receives FDA Approval to Manufacture Breast …” on February 06, 2018. Also Globenewswire.com published the news titled: “Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)” on January 25, 2018. Globenewswire.com‘s news article titled: “Sientra┬« Provides Update on FDA Review of US Manufacturing Facility” with publication date: January 30, 2018 was also an interesting one.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. The company has market cap of $218.08 million. The firm offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders. It currently has negative earnings. It also provides body contouring products; facial and nasal implants; scar management products under the bioCorneum and Silishield brand names; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.